Clinical Trials

JZP-386 Advances to Clinical Trial Evaluation

Jazz Pharmaceuticals plc and Concert Pharmaceuticals Inc have initiated the first Phase 1 clinical trial of JZP-386. JZP-386 is a deuterium-containing analog of sodium oxybate—the active ingredient in Xyrem (sodium oxybate) oral solution.